We are live on ! Find out more
OKYO

OKYO Pharma
OKYO

8 hedge funds and large institutions have $5.14M invested in OKYO Pharma in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

247% more capital invested

Capital invested by funds: $1.48M → $5.14M (+$3.66M)

60% more funds holding

Funds holding: 5 → 8 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.35% less ownership

Funds ownership: 8.19% → 6.84% (-1.4%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
4
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$146K
2
Renaissance Technologies
Renaissance Technologies
New York
+$105K
3
Citadel Advisors
Citadel Advisors
Florida
+$39.1K
4
Osaic Holdings
Osaic Holdings
Arizona
+$387

Top Sellers

Rank Fund Capital Flow
1
DIG
Dauntless Investment Group
New Hampshire
-$799K
2
UBS Group
UBS Group
Switzerland
-$296

OKYO Hedge Fund Activity: Q3 2025 in Review

8 of the 7,644 institutional investors tracked by Wall St. Rank reported a position in OKYO Pharma (OKYO) for Q3 2025, worth a combined $5.14M — up 247% from $1.48M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new OKYO positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Northern Trust, opening a new position worth an estimated $146K. The largest seller was Dauntless Investment Group, cutting an estimated $799K.

  • 8 institutional investors held OKYO Pharma (OKYO) as of Q3 2025, up from 5 in Q2 2025.
  • Funds reported $5.14M of OKYO Pharma stock for Q3 2025, up 247% quarter-over-quarter.
  • 4 funds opened new OKYO Pharma positions in Q3 2025 and 1 closed out, a net change of +3 holders.
  • The largest OKYO Pharma buyer in Q3 2025 was Northern Trust, an estimated $146K added.
  • The largest OKYO Pharma seller in Q3 2025 was Dauntless Investment Group, an estimated $799K sold.

Based on aggregated 13F filings for Q3 2025.